Vimr E R, Troy F A
J Bacteriol. 1985 Nov;164(2):854-60. doi: 10.1128/jb.164.2.854-860.1985.
In Escherichia coli, synthesis of sialic acid is not regulated by allosteric inhibition mediated by cytidine 5'-monophospho-N-acetylneuraminic acid (CMP-NeuNAc). Evidence for the lack of metabolic control by feedback inhibition was demonstrated by measuring the intracellular level of sialic acid and CMP-NeuNAc in mutants defective in sialic acid polymerization and in CMP-NeuNAc synthesis. Polymerization-defective mutants could not synthesize the polysialic acid capsule and accumulated ca. 25-fold more CMP-NeuNAc than the wild type. Mutants unable to activate sialic acid because of a defect in CMP-NeuNAc synthetase accumulated ca. sevenfold more sialic acid than the wild type. An additional threefold increase in sialic acid levels occurred when a mutation resulting in loss of N-acylneuraminate pyruvate-lysase (sialic acid aldolase) was introduced into the CMP-NeuNAc synthetase-deficient mutant. The aldolase mutation could not be introduced into the polymerization-defective mutant, suggesting that any further increase in the intracellular CMP-NeuNAc concentration was toxic. These results show that sialic acid aldolase can regulate the intracellular concentration of sialic acid and therefore the concentration of CMP-NeuNAc. We conclude that regulation of aldolase, mediated by sialic acid induction, is necessary not only for dissimilating sialic acid (E.R. Vimr and F. A. Troy, J. Bacteriol. 164:845-853, 1985) but also for modulating the level of metabolic intermediates in the sialic acid pathway. In agreement with this conclusion, an increase in the intracellular sialic acid concentration was correlated with an increase in aldolase activity. Direct evidence for the central role of aldolase in regulating the metabolic flux of sialic adid in E. coli was provided by the finding that exogenous radiolabeled sialic acid was specifically incorporated into sialyl polymer in aldolase-negative strain but not in the wild type.
在大肠杆菌中,唾液酸的合成不受胞苷5'-单磷酸-N-乙酰神经氨酸(CMP-NeuNAc)介导的变构抑制调节。通过测量唾液酸聚合缺陷型和CMP-NeuNAc合成缺陷型突变体中唾液酸和CMP-NeuNAc的细胞内水平,证明了缺乏反馈抑制的代谢控制证据。聚合缺陷型突变体无法合成多聚唾液酸荚膜,其CMP-NeuNAc的积累量比野生型多约25倍。由于CMP-NeuNAc合成酶缺陷而无法激活唾液酸的突变体,其唾液酸积累量比野生型多约7倍。当将导致N-酰基神经氨酸丙酮酸裂解酶(唾液酸醛缩酶)缺失的突变引入CMP-NeuNAc合成酶缺陷型突变体时,唾液酸水平又额外增加了三倍。醛缩酶突变不能引入聚合缺陷型突变体,这表明细胞内CMP-NeuNAc浓度的任何进一步增加都是有毒的。这些结果表明,唾液酸醛缩酶可以调节唾液酸的细胞内浓度,从而调节CMP-NeuNAc的浓度。我们得出结论,由唾液酸诱导介导的醛缩酶调节不仅对于唾液酸的异化作用(E.R. Vimr和F.A. Troy,《细菌学杂志》164:845 - 853,1985)是必要的,而且对于调节唾液酸途径中代谢中间体的水平也是必要的。与这一结论一致的是,细胞内唾液酸浓度的增加与醛缩酶活性的增加相关。通过以下发现提供了醛缩酶在调节大肠杆菌中唾液酸代谢通量的核心作用的直接证据:外源性放射性标记的唾液酸在醛缩酶阴性菌株中特异性地掺入唾液酸聚合物中,而在野生型中则不然。